4.6 Article

The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

Tim Raine et al.

JOURNAL OF CROHNS & COLITIS (2022)

Article Gastroenterology & Hepatology

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment

Antonino Spinelli et al.

Summary: This article is the second in a series of European Crohn's and Colitis Organisation [ECCO] articles on the management of adult patients with ulcerative colitis [UC]. It provides information on the medical treatment of acute severe ulcerative colitis [ASUC] and the surgical management of medically refractory UC patients.

JOURNAL OF CROHNS & COLITIS (2022)

Review Gastroenterology & Hepatology

A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation

Masahiro Kishi et al.

Summary: Clinical and endoscopic indices used in clinical trials for inflammatory bowel disease have been evaluated and reviewed, with the emergence of new indices. Representative indices in clinical trials cover various definitions, including clinical and endoscopic response or remission.

JOURNAL OF GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Anti-proteinase 3 antineutrophil cytoplasmic antibody reflects disease activity and predicts the response to steroid therapy in ulcerative colitis

Yuki Aoyama et al.

Summary: PR3-ANCA positivity is associated with disease severity and predicts the response to steroid therapy in UC patients. Conversion of PR3-ANCA to negative may be related to achieving clinical remission.

BMC GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients

April N. Naegeli et al.

Summary: Understanding ulcerative colitis disease activity assessed via different permutations of Mayo Scores can help predict endoscopic and Physician's Global Assessment scores, serving as proxies for the full Mayo Score in clinical practice/trials. This study provides insights into evaluating disease activity in patients with ulcerative colitis without the need for endoscopy or Physician's Global Assessment.

CROHNS & COLITIS 360 (2021)

Article Gastroenterology & Hepatology

Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients

April N. Naegeli et al.

Summary: Understanding ulcerative colitis disease activity through Mayo Score assessment can help clinicians apply clinical trial results to practice. Partial/modified Mayo Scores can predict endoscopic and Physician's Global Assessment scores, serving as proxies for the full Mayo Score in clinical practice and trials.

CROHNS & COLITIS 360 (2021)

Review Gastroenterology & Hepatology

Review article: faecal calprotectin and histologic remission in ulcerative colitis

Ferdinando D'Amico et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Review Gastroenterology & Hepatology

Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update

Emanuel Burri et al.

DIGESTION (2020)

Article Gastroenterology & Hepatology

Urotensin II receptor expression in patients with ulcerative colitis: a pilot study

Antonietta G. Gravina et al.

MINERVA GASTROENTEROLOGICA E DIETOLOGICA (2020)

Article Gastroenterology & Hepatology

IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology

Gareth-Rhys Jones et al.

Article Gastroenterology & Hepatology

CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis

David J. Gibson et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)

Editorial Material Health Care Sciences & Services

Precision Medicine

Alan R. Weil

HEALTH AFFAIRS (2018)

Article Biochemistry & Molecular Biology

An investigation into the origin of the biased agonism associated with the urotensin II receptor activation

Diego Brancaccio et al.

JOURNAL OF PEPTIDE SCIENCE (2015)

Article Gastroenterology & Hepatology

The global burden of IBD: from 2015 to 2025

Gilaad G. Kaplan

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease

Taina Sipponen et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)

Article Medicine, General & Internal

Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans

Alessandro Federico et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Gastroenterology & Hepatology

European consensus on the histopathology of inflammatory bowel disease

F. Magro et al.

JOURNAL OF CROHNS & COLITIS (2013)

Article Biochemistry & Molecular Biology

New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide

Alfonso Carotenuto et al.

JOURNAL OF PEPTIDE SCIENCE (2013)

Review Medicine, General & Internal

A catalogue of reporting guidelines for health research

I. Simera et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Gastroenterology & Hepatology

The pattern and outcome of acute severe colitis

Lotte C. Dinesen et al.

JOURNAL OF CROHNS & COLITIS (2010)

Review Pharmacology & Pharmacy

The role of urotensin II in cardiovascular and renal physiology and diseases

Yi-Chun Zhu et al.

BRITISH JOURNAL OF PHARMACOLOGY (2006)

Article Medicine, General & Internal

Infliximab for induction and maintenance therapy for ulcerative colitis

P Rutgeerts et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Biochemistry & Molecular Biology

Recent structure-activity studies of the peptide hormone urotensin-II, a potent vasoconstrictor

P Grieco et al.

CURRENT MEDICINAL CHEMISTRY (2004)